Karin Löw

2.9k total citations · 1 hit paper
23 papers, 2.3k citations indexed

About

Karin Löw is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Karin Löw has authored 23 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 4 papers in Cognitive Neuroscience. Recurrent topics in Karin Löw's work include Neuroscience and Neuropharmacology Research (6 papers), Nerve injury and regeneration (5 papers) and Nanoparticle-Based Drug Delivery (3 papers). Karin Löw is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Nerve injury and regeneration (5 papers) and Nanoparticle-Based Drug Delivery (3 papers). Karin Löw collaborates with scholars based in Switzerland, Germany and United States. Karin Löw's co-authors include Uwe Rudolph, Hanns Möhler, Ruth Keist, Jean‐Marc Fritschy, Florence Crestani, Jack A. Benson, Horst Bluethmann, Ina Brünig, Dietmar Benke and Thomas Rülicke and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Neuroscience.

In The Last Decade

Karin Löw

23 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular and Neuronal Substrate for the Selective Attenuation of Anxiety

2000 747 citations Karin Löw, Florence Crestani et al. Science profile →

Peers

Countries citing papers authored by Karin Löw

Since Specialization

Citations

This map shows the geographic impact of Karin Löw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Löw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Löw more than expected).

Fields of papers citing papers by Karin Löw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Löw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Löw. The network helps show where Karin Löw may publish in the future.

Co-authorship network of co-authors of Karin Löw

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Löw. A scholar is included among the top collaborators of Karin Löw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Löw. Karin Löw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Luminescent reporter cells enable the identification of broad‐spectrum antivirals against emerging viruses 2023 ·Journal of Medical Virology ·Karin Löw, (unknown), (unknown), Miriam Becker, (unknown), (unknown), Dirk Schaudien, Lisa Oestereich, Armin Braun, Stefan Kunz, Gisa Gerold	2
2	Molecular evolution of the proopiomelanocortin system in Barn owl species 2020 ·PLoS ONE ·Karin Löw, Anne‐Lyse Ducrest, Luis M. San‐Jose, (unknown), (unknown), Nabil G. Seidah, Antonella Pasquato, Stefan Kunz, Alexandre Roulin	3
3	A novel cell‐based sensor detecting the activity of individual basic proprotein convertases 2019 ·FEBS Journal ·Karin Löw, Kornelia Hardes, Chiara Fedeli, Nabil G. Seidah, Daniel B. Constam, Antonella Pasquato, Torsten Steinmetzer, Alexandre Roulin, Stefan Kunz	4
4	In vitro and in vivo investigations of upconversion and NIR emitting Gd2O3:Er3+,Yb3+ nanostructures for biomedical applications 2012 ·Journal of Materials Science Materials in Medicine ·Eva Hemmer, (unknown), Tomoyoshi Yamano, (unknown), Yvonne Kohl, Karin Löw, N. Venkatachalam, Hiroshi Hyodo, Hidehiro Kishimoto, Kohei Soga	29
5	Targeted human serum albumin nanoparticles for specific uptake in EGFR-Expressing colon carcinoma cells 2011 ·Nanomedicine Nanotechnology Biology and Medicine ·Karin Löw, Matthias G. Wacker, Sylvia Wagner, Klaus Langer, Hagen von Briesen	57
6	Use of viral vectors to create animal models for Parkinson's disease 2011 ·Neurobiology of Disease ·Karin Löw, Patrick Aebischer	45
7	Comparison of intracellular accumulation and cytotoxicity of freemTHPC andmTHPC-loaded PLGA nanoparticles in human colon carcinoma cells 2011 ·Nanotechnology ·Karin Löw, Thomas J. Knobloch, Sylvia Wagner, Arno Wiehe, Andrea Engel, Klaus Langer, Hagen von Briesen	26
8	Cytotoxicity of Triptolide and Triptolide loaded polymeric micelles in vitro 2011 ·Toxicology in Vitro ·(unknown), Karin Löw, Sylvia Wagner, Xiangliang Yang, Hagen von Briesen, Shengquan Zou	15
9	A dual promoter lentiviral vector for the in vivo evaluation of gene therapeutic approaches to axon regeneration after spinal cord injury 2010 ·Gene Therapy ·Karin Löw, Armin Blesch, Julia Herrmann, Mark H. Tuszynski	21
10	Netrin-1 Is a Novel Myelin-Associated Inhibitor to Axon Growth 2008 ·Journal of Neuroscience ·Karin Löw, Maya Deza Culbertson, Frank Bradke, Marc Tessier‐Lavigne, Mark H. Tuszynski	106
11	Specific GABA _A Circuits for Visual Cortical Plasticity 2004 ·Science ·Michela Fagiolini, Jean‐Marc Fritschy, Karin Löw, Hanns Möhler, Uwe Rudolph, Takao K. Hensch	374
12	Modulation of rhythmic brain activity by diazepam: GABA _A receptor subtype and state specificity 2004 ·Proceedings of the National Academy of Sciences ·Caroline Kopp, Uwe Rudolph, Karin Löw, Irene Tobler	103
13	NT-3 gene delivery elicits growth of chronically injured corticospinal axons and modestly improves functional deficits after chronic scar resection 2003 ·Experimental Neurology ·Mark H. Tuszynski, Ray Grill, Leonard L. Jones, (unknown), Armin Blesch, Karin Löw, Steve Lacroix, Paul Lu	113
14	Molecular Targets for the Myorelaxant Action of Diazepam 2001 ·Molecular Pharmacology ·Florence Crestani, Karin Löw, Ruth Keist, (unknown), Hanns Möhler, Uwe Rudolph	184
15	Molecular Targets for the Myorelaxant Action of Diazepam 2001 ·Molecular Pharmacology ·Florence Crestani, Karin Löw, Ruth Keist, (unknown), Hanns Möhler, Uwe Rudolph	16
16	Molecular and Neuronal Substrate for the Selective Attenuation of Anxiety breakdown → 2000 ·Science ·Karin Löw, Florence Crestani, Ruth Keist, Dietmar Benke, Ina Brünig, Jack A. Benson, Jean‐Marc Fritschy, Thomas Rülicke, Horst Bluethmann, Hanns Möhler, Uwe Rudolph	747
17	Pharmacology of recombinant γ‐aminobutyric acid_A receptors rendered diazepam‐insensitive by point‐mutated α‐subunits 1998 ·FEBS Letters ·Jack A. Benson, Karin Löw, Ruth Keist, H. Möhler, Uwe Rudolph	154
18	The L2/HNK‐1 Carbohydrate is Carried by the Myelin Associated Glycoprotein and Sulphated Glucuronyl Glycolipids in Muscle but not Cutaneous Nerves of Adult Mice 1994 ·European Journal of Neuroscience ·Karin Löw, Georg Orberger, Brigitte Schmitz, Rudolf Martini, Melitta Schachner	39
19	Immunoglobulins in Urine from Patients with Ileal and Colonic Conduits and Reservoirs 1985 ·The Journal of Urology ·Wiking Månsson, S. Colleen, Karin Löw, Per‐Anders Mårdh, Arne Lundblad	16
20	Purification of a Specific Placental Plasminogen Activator Inhibitor by Monoclonal Antibody and Its Complex Formation with Plasminogen Activator 1985 ·Thrombosis and Haemostasis ·Birger Åstedt, Ingegerd Lecander, Thomas Brodin, Arne Lundblad, Karin Löw	135

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact